Patent · US Active

Anti-angiogenic methods and compositions

US8012946B1 · kind B1 · utility

15Cited by

54References

10Claims

0Family size

Assignee

Sangamo Biosciences, Inc. · US

Inventors

H. Steve Zhang · Richmond, US
Philip D. Gregory · Richmond, US
Edward J. Rebar · Richmond, US

Key dates

Filing date	Jan 9, 2008
Grant date	Sep 6, 2011
Priority date	—
Expiry date	Mar 22, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2799/028
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are methods and compositions for treatment of conditions requiring inhibition of angiogenesis. Such conditions include those characterized by neovascularization, such as retinopathies, macular degeneration and various malignancies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.